CSJA:FRA
CSL ADR
၂၉.၂၀ €
arrow_upward
+၁.၃၉%(+၀.၄၀) 1D
အောက် ၂၀, GMT+၂ ၀၈:၁၂:၃၄ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Open
၂၉.၂၀ €
High
၂၉.၂၀ €
Low
၂၉.၂၀ €
Mkt. cap
ဋေ ၉.၄၂ ထ
Avg. vol.
၁၀.၀၀
Volume
၀.၀၀
52-wk high
၄၃.၄၀ €
52-wk low
၁၂.၇၀ €
No. of employees
၃ သောင်း
Open
၂၉.၂၀ €
High
၂၉.၂၀ €
Low
၂၉.၂၀ €
Mkt. cap
ဋေ ၉.၄၂ ထ
Avg. vol.
၁၀.၀၀
Volume
၀.၀၀
52-wk high
၄၃.၄၀ €
52-wk low
၁၂.၇၀ €
No. of employees
၃ သောင်း
News stories
From web sources and news partners
Kalkine
·
ပြီးခဲ့သည့် ၄ နာရီ
CSL Limited (ASX:CSL) Details Business Restructuring and Financial Results
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂၀ နာရီ
CSL stock: CSL annual meeting is set for October 27, 2026
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
CSL stock: Sydney gains 0.96 percent ahead of the Xetra open
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees၂.၉ သောင်း
Founded၁၉၁၆
Headquartersမဲလ်ဘုန်းမြို့, ဝိတိုရိယ ပြည်နယ်, ဩစတြေးလျ
Sector-
Websitecsl.com